The SVP, CBO and CFO of Novavax (NVAX) is Selling Shares


Yesterday, the SVP, CBO and CFO of Novavax (NVAX), John Trizzino, sold shares of NVAX for $31.91K.

This is Trizzino’s first Sell trade following 5 Buy transactions.

See today’s analyst top recommended stocks >>

The company has a one-year high of $51.60 and a one-year low of $4.01. Currently, Novavax has an average volume of 850.82K.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Novavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology.

Read More on NVAX:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts